SK281914B6 - Derivát piperidinylmetyloxazolidinónu, spôsob jeho prípravy, farmaceutický prostriedok, ktorý ho obsahuje, a použitie - Google Patents

Derivát piperidinylmetyloxazolidinónu, spôsob jeho prípravy, farmaceutický prostriedok, ktorý ho obsahuje, a použitie Download PDF

Info

Publication number
SK281914B6
SK281914B6 SK1061-96A SK106196A SK281914B6 SK 281914 B6 SK281914 B6 SK 281914B6 SK 106196 A SK106196 A SK 106196A SK 281914 B6 SK281914 B6 SK 281914B6
Authority
SK
Slovakia
Prior art keywords
piperidinylmethyl
oxazolidin
aminobenzyl
acetylaminobenzyl
compounds
Prior art date
Application number
SK1061-96A
Other languages
English (en)
Slovak (sk)
Other versions
SK106196A3 (en
Inventor
Helmut Pr�cher
Gerd Bartoszyk
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of SK106196A3 publication Critical patent/SK106196A3/sk
Publication of SK281914B6 publication Critical patent/SK281914B6/sk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
SK1061-96A 1995-08-25 1996-08-14 Derivát piperidinylmetyloxazolidinónu, spôsob jeho prípravy, farmaceutický prostriedok, ktorý ho obsahuje, a použitie SK281914B6 (sk)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19531321A DE19531321A1 (de) 1995-08-25 1995-08-25 Piperidinylmethyloxazolidinone

Publications (2)

Publication Number Publication Date
SK106196A3 SK106196A3 (en) 1997-04-09
SK281914B6 true SK281914B6 (sk) 2001-09-11

Family

ID=7770390

Family Applications (1)

Application Number Title Priority Date Filing Date
SK1061-96A SK281914B6 (sk) 1995-08-25 1996-08-14 Derivát piperidinylmetyloxazolidinónu, spôsob jeho prípravy, farmaceutický prostriedok, ktorý ho obsahuje, a použitie

Country Status (27)

Country Link
US (1) US5714502A (fr)
EP (1) EP0763535B1 (fr)
JP (1) JPH09124646A (fr)
KR (1) KR970010766A (fr)
CN (1) CN1067391C (fr)
AR (1) AR004185A1 (fr)
AT (1) ATE228517T1 (fr)
AU (1) AU715310B2 (fr)
BR (1) BR9603509A (fr)
CA (1) CA2184052A1 (fr)
CO (1) CO4750661A1 (fr)
CZ (1) CZ291446B6 (fr)
DE (2) DE19531321A1 (fr)
DK (1) DK0763535T3 (fr)
ES (1) ES2187597T3 (fr)
HU (1) HUP9602324A3 (fr)
MX (1) MX9603567A (fr)
NO (1) NO306993B1 (fr)
PL (1) PL185141B1 (fr)
PT (1) PT763535E (fr)
RU (1) RU2175970C2 (fr)
SI (1) SI0763535T1 (fr)
SK (1) SK281914B6 (fr)
TR (1) TR199600656A2 (fr)
TW (1) TW426680B (fr)
UA (1) UA43860C2 (fr)
ZA (1) ZA967201B (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19739332C1 (de) * 1997-09-09 1998-11-26 Merck Patent Gmbh Piperidinylmethyloxazolidinon-Derivat
JP2004516295A (ja) * 2000-12-21 2004-06-03 ワーナー−ランバート・カンパニー、リミテッド、ライアビリティ、カンパニー サブタイプ選択的なｎ−メチル−ｄ−アスパラギン酸拮抗薬としてのピペリジン誘導体
TW200302095A (en) * 2002-01-25 2003-08-01 Upjohn Co Oxazolidinone cotherapy
ATE430976T1 (de) * 2003-07-14 2009-05-15 Lg Electronics Inc Einmalbeschreibbarer optischer datenträger, verfahren und vorrichtung zum aufzeichnen von verwaltungsinformationen auf einem einmalbeschreibbaren optischen datenträger
GB201317609D0 (en) 2013-10-04 2013-11-20 Cancer Rec Tech Ltd Inhibitor compounds
GB201505658D0 (en) 2015-04-01 2015-05-13 Cancer Rec Tech Ltd Inhibitor compounds
GB201617103D0 (en) 2016-10-07 2016-11-23 Cancer Research Technology Limited Compound

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0713017B2 (ja) * 1986-06-18 1995-02-15 日本ケミファ株式会社 脳細胞保護作用を有する医薬組成物
DE3723797A1 (de) * 1987-07-18 1989-01-26 Merck Patent Gmbh Oxazolidinone
DE4005371A1 (de) * 1990-02-21 1991-08-22 Merck Patent Gmbh Oxazolidinone
DE4017211A1 (de) * 1990-05-29 1991-12-05 Merck Patent Gmbh Oxazolidinone
DE4324393A1 (de) * 1993-07-21 1995-01-26 Merck Patent Gmbh 4-Aryloxy- und 4-Arylthiopiperidinderivate

Also Published As

Publication number Publication date
ATE228517T1 (de) 2002-12-15
DK0763535T3 (da) 2003-03-17
TW426680B (en) 2001-03-21
AU6215196A (en) 1997-02-27
DE19531321A1 (de) 1997-02-27
PL185141B1 (pl) 2003-02-28
PL315801A1 (en) 1997-03-03
CZ291446B6 (cs) 2003-03-12
ES2187597T3 (es) 2003-06-16
TR199600656A3 (fr) 1997-03-21
SK106196A3 (en) 1997-04-09
CZ233896A3 (en) 1997-03-12
BR9603509A (pt) 1998-05-12
RU2175970C2 (ru) 2001-11-20
JPH09124646A (ja) 1997-05-13
DE59609913D1 (de) 2003-01-09
MX9603567A (es) 1997-06-28
UA43860C2 (uk) 2002-01-15
NO306993B1 (no) 2000-01-24
US5714502A (en) 1998-02-03
AU715310B2 (en) 2000-01-20
CN1148594A (zh) 1997-04-30
CA2184052A1 (fr) 1997-02-26
EP0763535B1 (fr) 2002-11-27
AR004185A1 (es) 1998-11-04
ZA967201B (en) 1997-03-03
CO4750661A1 (es) 1999-03-31
SI0763535T1 (en) 2003-08-31
TR199600656A2 (tr) 1997-03-21
HU9602324D0 (en) 1996-10-28
HUP9602324A3 (en) 1998-10-28
HUP9602324A2 (hu) 1998-07-28
NO963524L (no) 1997-02-26
NO963524D0 (no) 1996-08-23
KR970010766A (ko) 1997-03-27
EP0763535A1 (fr) 1997-03-19
PT763535E (pt) 2003-04-30
CN1067391C (zh) 2001-06-20

Similar Documents

Publication Publication Date Title
SK283870B6 (sk) 2-[5-(4-Fluórfenyl)-3-pyridylmetylaminometyl]chróman, spôsob jeho prípravy, jeho použitie a farmaceutický prostriedok, ktorý ho obsahuje
EP0300272B1 (fr) Oxazolidinones
CZ304702B6 (cs) (4R) a (4S) diastereoizomery (2S)-2-[2-oxo-4-propylpyrrolidinyl] butanamidu, farmaceutická kompozice s jejich obsahem a jejich použití
EP0736525B1 (fr) Benzonitriles comme 5-HT agonistes et antagonistes
EP0741133B1 (fr) Antagonistes des récepteurs d'adhésion
SK46599A3 (en) Use of condensated (hetaryl-substituted) 1-benzal-3-pyrazol derivates for treating special diseases of the cardiovascular and the central nervous systems
EP1068202B1 (fr) 1-(3-heteroarylpropyl- ou -prop-2-enyl)-4-benzylpiperidines utilisees comme antagonistes du recepteur de nmda
EP0512350A2 (fr) Dérivés de l'indole
EP0964863B1 (fr) Oxazolidinones s'utilisant comme 5-ht2a-antagonistes
SK281914B6 (sk) Derivát piperidinylmetyloxazolidinónu, spôsob jeho prípravy, farmaceutický prostriedok, ktorý ho obsahuje, a použitie
DE69109132T2 (de) Indanderivate.
EP0635505B1 (fr) Dérivés de 4-aryloxy et 4-arylthio-piperidine
EP0007399B1 (fr) Indolylalcoylamines, préparations pharmaceutiques les contenant et procédé pour leur fabrication
SK5942002A3 (en) Isoxazole derivatives to be used as phosphodiesterase vii inhibitors, use thereof and pharmaceutical composition comprising the same
EP0000108A1 (fr) Benzo(b)thiéno-pyridines, leur procédé de préparation et composition thérapeutique les contenant
SK53699A3 (en) 6-{3-[4-(fluorobenzyle)-piperidine-1-yl]-propionyl}-3h- -benzoxazole-2-one, method for its preparation, its use and pharmaceutical composition containing the same
EP0224794A2 (fr) Dérivés amines cycliques, médicaments contenant ces composés et leur procédé de préparation
DE2827874A1 (de) Indolalkylamine und verfahren zu ihrer herstellung
EP1202966B1 (fr) Alcools de piperidine
FI61182B (fi) Foerfarande foer framstaellning av farmaceutiskt aktiva butylaminderivat
SK18596A3 (en) Oxazolidinone derivative, preparation method thereof and pharmaceutical composition containing them
US3655661A (en) Benzothiadiazole compounds
KR100437561B1 (ko) 신규헤테로고리화합물
DE60113300T2 (de) Piperazinylcarbonylchinoline und isochinoline
US3764684A (en) Novel indolobenzazepine derivatives, useful as tranquilizers